A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
Phase of Trial: Phase I/II
Latest Information Update: 22 May 2017
At a glance
- Drugs AAV-hAADC (Primary)
- Indications Inborn error amino acid metabolic disorders
- Focus Therapeutic Use
- 16 May 2017 Status changed from recruiting to completed.
- 10 May 2017 Results published in an Agilis Biotherapeutics Media Release
- 10 May 2017 According to an Agilis Biotherapeutics media release, this trial is performed under the direction of principal investigator Paul Hwu.